Clinical Trial Update: Haploidentical Stem Cell Transplantation for Children With Therapy Resistant Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating haploidentical stem cell transplantation for children with therapy-resistant leukemia (ALL and AML) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Snippet

Sponsor: Lund University Hospital | Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED